Advertisement
Editorial| Volume 19, ISSUE 5, P373-374, May 2018

Can Muscle Strength Be Considered a Composite Biomarker of Sarcopenia?

      Changes in the age-specific prevalence and severity of functional impairment are expected to have major implications for health care costs.
      • Rantz M.J.
      • Popejoy L.
      • Vogelsmeier A.
      • et al.
      Successfully reducing hospitalizations of nursing home residents: Results of the Missouri quality initiative.
      According to the Global Health and Aging report released by the World Health Organization, “the number of people aged 65 or older is projected to grow from an estimated 524 million in 2010 to nearly 1.5 billion in 2050, with most of the increase in developing countries.”
      World Health Organization
      Global health and ageing.
      Although aging is not synonymous with poor health or loss of independence, the risk of developing diseases and disabilities increases with advancing age.
      • Landi F.
      • Calvani R.
      • Tosato M.
      • et al.
      Age-related variations of muscle mass, strength, and physical performance in community-dwellers: Results from the Milan EXPO Survey.
      Changes in the age structure of society and the associated demand for support and care pose a major threat to the sustainability of health care systems.
      • Mander T.
      Longevity and healthy ageing—Will healthcare be drowned by the grey tsunami or sunk by the demographic iceberg?.
      Reducing the burden of disability and enabling older adults to maintain their independence are therefore perceived as high public health priorities.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rantz M.J.
        • Popejoy L.
        • Vogelsmeier A.
        • et al.
        Successfully reducing hospitalizations of nursing home residents: Results of the Missouri quality initiative.
        J Am Med Dir Assoc. 2017; 18: 960-966
        • World Health Organization
        Global health and ageing.
        (Available at:) (Accessed December 23, 2017)
        • Landi F.
        • Calvani R.
        • Tosato M.
        • et al.
        Age-related variations of muscle mass, strength, and physical performance in community-dwellers: Results from the Milan EXPO Survey.
        J Am Med Dir Assoc. 2017; 18: 88.e17-88.e24
        • Mander T.
        Longevity and healthy ageing—Will healthcare be drowned by the grey tsunami or sunk by the demographic iceberg?.
        Post Reprod Health. 2014; 20: 8-10
        • McGrath R.
        • Robinson-Lane S.G.
        • Peterson M.D.
        • et al.
        Muscle strength and functional limitations: Preserving function in older Mexican Americans.
        J Am Med Dir Assoc. 2018; 19: 391-398
        • Marzetti E.
        • Calvani R.
        • Tosato M.
        • et al.
        Sarcopenia: An overview.
        Aging Clin Exp Res. 2017; 29: 11-17
        • Bruyère O.
        • Buckinx F.
        • Beaudart C.
        • et al.
        How clinical practitioners assess frailty in their daily practice: An international survey.
        Aging Clin Exp Res. 2017; 29: 905-912
        • Landi F.
        • Calvani R.
        • Cesari M.
        • et al.
        Sarcopenia: An overview on current definitions, diagnosis and treatment.
        Curr Protein Pept Sci. 2017 Jun 6; ([Epub ahead of print])
        • McGrath R.
        • Vincent B.M.
        • Al Snih S.
        • et al.
        The association between muscle weakness and incident diabetes in older Mexican Americans.
        J Am Med Dir Assoc. 2017; 18: 452.e7-452.e12
        • Landi F.
        • Martone A.M.
        • Calvani R.
        • Marzetti E.
        Sarcopenia risk screening tool: A new strategy for clinical practice.
        J Am Med Dir Assoc. 2014; 15: 613-614
        • Buckinx F.
        • Landi F.
        • Cesari M.
        • et al.
        Pitfalls in the measurement of muscle mass: A need for a reference standard.
        J Cachexia Sarcopenia Muscle. 2018; 9: 269-278
        • Beaudart C.
        • McCloskey E.
        • Bruyère O.
        • et al.
        Sarcopenia in daily practice: Assessment and management.
        BMC Geriatr. 2016; 16: 170
        • Tosato M.
        • Marzetti E.
        • Cesari M.
        • et al.
        Measurement of muscle mass in sarcopenia: From imaging to biochemical markers.
        Aging Clin Exp Res. 2017; 29: 19-27
        • Landi F.
        • Liperoti R.
        • Fusco D.
        • et al.
        Sarcopenia and mortality among older nursing home residents.
        J Am Med Dir Assoc. 2012; 13: 121-126
        • Landi F.
        • Calvani R.
        • Cesari M.
        • et al.
        Sarcopenia as the biological substrate of physical frailty.
        Clin Geriatr Med. 2015; 31: 367-374
        • Studenski S.A.
        • Peters K.W.
        • Alley D.E.
        • et al.
        The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates.
        J Gerontol A Biol Sci Med Sci. 2014; 69: 547-558
        • Cruz-Jentoft A.J.
        • Landi F.
        • Topinková E.
        • Michel J.P.
        Understanding sarcopenia as a geriatric syndrome.
        Curr Opin Clin Nutr Metab Care. 2010; 13: 1-7
        • Fornelli G.
        • Isaia G.C.
        • D'Amelio P.
        Ageing, muscle and bone.
        J Gerontol Geriatr. 2016; 64: 75-80
        • Landi F.
        • Cesari M.
        • Calvani R.
        • et al.
        The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” (SPRINTT) randomized controlled trial: Design and methods.
        Aging Clin Exp Res. 2017; 29: 89-100
        • Cesari M.
        • Marzetti E.
        • Calvani R.
        • et al.
        The need of operational paradigms for frailty in older persons: The SPRINTT project.
        Aging Clin Exp Res. 2017; 29: 3-10
        • Morandi A.
        • Onder G.
        • Fodri L.
        • et al.
        The association between the probability of sarcopenia and functional outcomes in older patients undergoing in-hospital rehabilitation.
        J Am Med Dir Assoc. 2015; 16: 951-956